IMMUNIC, INC. — Director's Dealing 2016

Jan 27, 2016

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2015-12-31

Reporting Person: Winters Terence E. (Director, Co-Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-23	Common Stock	G	3600	—	Disposed	186966	Direct

Footnotes

F1: The reported disposition represents gifts of shares to family members. The reporting person disclaims any direct or indirect beneficial ownership in the gifted shares.